Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up

Petar Mamula; Jonathan E. Markowitz; Louis J. Cohen; Daniel von Allmen; Robert N. Baldassano

doi:10.1097/00005176-200403000-00013

Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up

Petar Mamula, Jonathan E. Markowitz, Louis J. Cohen, Daniel von Allmen, Robert N. Baldassano

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Abstract

The role of infliximab in treating pediatric ulcerative colitis (UC) is not defined. The authors previously have described their experience with the open label use of infliximab in nine children with moderate to severe UC. The aim of this study was to describe the outcome of these patients after a minimum 2-year follow-up and to describe the responses of eight additional patients to this medication.

Original language	English
Pages (from-to)	298-301
Number of pages	4
Journal	Journal of Pediatric Gastroenterology and Nutrition
Volume	38
Issue number	3
DOIs	https://doi.org/10.1097/00005176-200403000-00013
State	Published - Mar 2004
Externally published	Yes

Keywords

Infliximab
Pediatric
Ulcerative colitis

Access to Document

10.1097/00005176-200403000-00013

Cite this

@article{b4056d44acfb4a749e10a3e394d72c6f,

title = "Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up",

abstract = "The role of infliximab in treating pediatric ulcerative colitis (UC) is not defined. The authors previously have described their experience with the open label use of infliximab in nine children with moderate to severe UC. The aim of this study was to describe the outcome of these patients after a minimum 2-year follow-up and to describe the responses of eight additional patients to this medication.",

keywords = "Infliximab, Pediatric, Ulcerative colitis",

author = "Petar Mamula and Markowitz, {Jonathan E.} and Cohen, {Louis J.} and {von Allmen}, Daniel and Baldassano, {Robert N.}",

year = "2004",

month = mar,

doi = "10.1097/00005176-200403000-00013",

language = "English",

volume = "38",

pages = "298--301",

journal = "Journal of Pediatric Gastroenterology and Nutrition",

issn = "0277-2116",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "3",

}

TY - JOUR

T1 - Infliximab in Pediatric Ulcerative Colitis

T2 - Two-year Follow-up

AU - Mamula, Petar

AU - Markowitz, Jonathan E.

AU - Cohen, Louis J.

AU - von Allmen, Daniel

AU - Baldassano, Robert N.

PY - 2004/3

Y1 - 2004/3

N2 - The role of infliximab in treating pediatric ulcerative colitis (UC) is not defined. The authors previously have described their experience with the open label use of infliximab in nine children with moderate to severe UC. The aim of this study was to describe the outcome of these patients after a minimum 2-year follow-up and to describe the responses of eight additional patients to this medication.

AB - The role of infliximab in treating pediatric ulcerative colitis (UC) is not defined. The authors previously have described their experience with the open label use of infliximab in nine children with moderate to severe UC. The aim of this study was to describe the outcome of these patients after a minimum 2-year follow-up and to describe the responses of eight additional patients to this medication.

KW - Infliximab

KW - Pediatric

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=5044228720&partnerID=8YFLogxK

U2 - 10.1097/00005176-200403000-00013

DO - 10.1097/00005176-200403000-00013

M3 - Article

C2 - 15076630

AN - SCOPUS:5044228720

SN - 0277-2116

VL - 38

SP - 298

EP - 301

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

IS - 3

ER -

Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up

Abstract

Keywords

Access to Document

Fingerprint

Cite this